Infleqtion (CCCX) director’s options tied to merger and board pay

(Neutral)

Form Type

Rhea-AI Filing Summary

Infleqtion, Inc. director David B. Singer reported receiving two grants of stock options totaling 64,690 options. One block of 34,740 fully vested options reflects legacy ColdQuanta, Inc. awards that were automatically converted into Infleqtion options in connection with the Churchill Capital Corp X–ColdQuanta mergers and subsequent name change to Infleqtion, Inc.

The second grant covers 29,950 options tied to his board service, with one-third vesting on February 17, 2027 and the remainder vesting monthly over three years, subject to continued service. The economic benefit of his director compensation flows to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider SINGER DAVID B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	34,740	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	29,950	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 64,690 shares (Direct)

Footnotes (5)

F1. Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").
F2. Fully vested.
F3. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.
F4. The economic benefit of the director compensation provided in respect of the Reporting Person's board service passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
F5. 1/3rd of the shares underlying the option shall vest on February 17, 2027, and 1/36th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/18/2026 - 08:56 AM

FAQ

What insider transactions did David B. Singer report for CCCX?

David B. Singer reported two acquisitions of Infleqtion, Inc. stock options totaling 64,690 options. One grant reflects converted legacy ColdQuanta options, and the other is a new director compensation award with time-based vesting conditions tied to his continued board service.

How many Infleqtion (CCCX) stock options were granted to David B. Singer?

David B. Singer was granted 64,690 Infleqtion stock options in total. This consists of 34,740 fully vested options from converted ColdQuanta awards and 29,950 additional options that vest over time based on his ongoing service as a director.

What is the vesting schedule of David B. Singer’s new CCCX option grant?

For the 29,950-share option grant, one-third of the shares vest on February 17, 2027. The remaining two-thirds vest in equal monthly installments, with 1/36 of the total vesting each month thereafter, subject to Singer’s continued service through each vesting date.

How did the Churchill Capital Corp X and ColdQuanta merger affect CCCX stock options?

Legacy ColdQuanta stock options were automatically converted into Infleqtion, Inc. options with the same terms and conditions. This occurred pursuant to a merger agreement involving Churchill Capital Corp X and ColdQuanta, with Infleqtion, Inc. becoming the renamed acquiror after completion of the mergers.

Who receives the economic benefit of David B. Singer’s director compensation at CCCX?

The economic benefit from director compensation tied to David B. Singer’s board service passes to Maverick Ventures Investment Fund, L.P. via a management fee offset. Singer expressly disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in that investment fund.

Are David B. Singer’s converted CCCX options immediately exercisable?

The 34,740 stock options received through conversion of legacy ColdQuanta options are fully vested. A related footnote specifies that this grant is fully vested, meaning the options are not subject to additional vesting conditions under the terms described in the disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SINGER DAVID B

(Last)

(First)

(Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE

80027

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Churchill Capital Corp X/Cayman [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$0.9	02/13/2026		A⁽¹⁾		34,740		⁽²⁾	06/05/2034	Common Stock	34,740	⁽³⁾	34,740	D⁽⁴⁾
Stock Option (Right to Buy)	$13.22	02/13/2026		A		29,950		⁽⁵⁾	02/12/2036	Common Stock	29,950	$0	29,950	D⁽⁴⁾

Explanation of Responses:

1. Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").

2. Fully vested.

3. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.

4. The economic benefit of the director compensation provided in respect of the Reporting Person's board service passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

5. 1/3rd of the shares underlying the option shall vest on February 17, 2027, and 1/36th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

	/s/ Jason D. Hall, Attorney-in-Fact	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR